Global Pharmacovigilance And Drug Safety Software Market Size & Outlook
Global pharmacovigilance and drug safety software market, 2018-2030 (US$M)
Related Markets
Global pharmacovigilance and drug safety software market highlights
- The global pharmacovigilance and drug safety software market generated a revenue of USD 198.2 million in 2023 and is expected to reach USD 314.1 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 6.8% by 2030.
- In terms of segment, on-demand accounted for a revenue of USD 110.5 million in 2023.
- On-Demand is the most lucrative delivery mode segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, U.S. is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 198.2 million |
| Market revenue in 2030 | USD 314.1 million |
| Growth rate | 6.8% (CAGR from 2023 to 2030) |
| Largest segment | On-demand |
| Fastest growing segment | On-Demand |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | On-Premise, On-Demand |
Other key industry trends
- In terms of revenue, the North America accounted for 32.5% of the global pharmacovigilance and drug safety software market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, U.S. is the fastest growing regional market and is projected to reach USD 74.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pharmacovigilance And Drug Safety Software Market Scope
Pharmacovigilance And Drug Safety Software Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global pharmacovigilance and drug safety software market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmacovigilance and drug safety software market will help companies and investors design strategic landscapes.
On-demand was the largest segment with a revenue share of 55.75% in 2023. Horizon Databook has segmented the Global pharmacovigilance and drug safety software market based on on-premise, on-demand covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Pharmacovigilance And Drug Safety Software Delivery Mode Outlook (Revenue, USD Million, 2018-2030)
- On-Premise
- On-Demand
- Global Pharmacovigilance And Drug Safety Software End Use Outlook (Revenue, USD Million, 2018-2030)
- Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
- CROs/BPOs or PV service providers when outsourced
- Others
- Global Pharmacovigilance And Drug Safety Software Functionality Outlook (Revenue, USD Million, 2018-2030)
- Case data collection and management
- Adverse event reporting and analysis
- Signal detection and other safety risk assessment
Reasons to subscribe to Global pharmacovigilance and drug safety software market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global pharmacovigilance and drug safety software market databook
-
Our clientele includes a mix of pharmacovigilance and drug safety software market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global pharmacovigilance and drug safety software market , including forecasts for subscribers. This global databook contains high-level insights into Global pharmacovigilance and drug safety software market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global pharmacovigilance and drug safety software market size, by region, 2018-2030 (US$M)
Top 10 countries: Pharmacovigilance and drug safety software market size, 2023 (US$M)
Global pharmacovigilance and drug safety software market share, by delivery mode, 2023 & 2030 (%, US$M)
Pharmacovigilance and drug safety software market: Opportunity assessment by country
Global pharmacovigilance and drug safety software market, by region, 2023 (US$M)
| Delivery Mode | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 49.4 | 52.1 | 55.0 | 58.5 | 61.5 | 64.5 | 67.7 | 71.2 | 74.9 | 78.9 | 83.2 | 87.7 | 92.6 | 5.3% |
| Europe | 36.5 | 39.0 | 41.8 | 45.2 | 48.3 | 51.5 | 55.0 | 58.8 | 63.0 | 67.5 | 72.3 | 77.7 | 83.5 | 7.1% |
| Asia Pacific | 40.5 | 43.9 | 47.6 | 52.1 | 56.3 | 60.8 | 65.7 | 71.0 | 76.8 | 83.2 | 90.1 | 97.8 | 106.1 | 8.3% |
| Latin America | 10.9 | 11.4 | 12.0 | 12.9 | 13.6 | 14.3 | 15.1 | 15.9 | 16.8 | 17.8 | 18.8 | 19.9 | 21.1 | 5.8% |
| MEA | 5.3 | 5.5 | 5.9 | 6.3 | 6.7 | 7.1 | 7.5 | 7.9 | 8.4 | 8.9 | 9.5 | 10.1 | 10.8 | 6.2% |
| Overall | 142.6 | 151.8 | 162.3 | 174.9 | 186.3 | 198.2 | 211.0 | 224.8 | 239.9 | 256.2 | 273.9 | 293.2 | 314.1 | 6.8% |
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
